Serum IL-12p40: A novel biomarker for early prediction of minimal change disease relapse following glucocorticoids therapy
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.922193
Abstract: Background Minimal change disease (MCD) has a high recurrence rate, but currently, no biomarker can predict its recurrence. To this end, this study aimed at identifying potential serum cytokines as valuable biomarkers for predicting the… read more here.
Keywords: serum 12p40; biomarker; change disease; recurrence ... See more keywords